Global Metastatic Lung Adenocarcinoma Treatment Market Size & Outlook
The global metastatic lung adenocarcinoma treatment market size was estimated at USD 4,896.4 million in 2024 and is projected to reach USD 9,288.1 million by 2030, growing at a CAGR of 11.3% from 2025 to 2030.
Revenue, 2024 (US$M)
$4,896.4
Forecast, 2030 (US$M)
$9,288.1
CAGR, 2025 - 2030
11.3%
Report Coverage
Worldwide
Global metastatic lung adenocarcinoma treatment market, 2018-2030 (US$M)
Related Markets
Global metastatic lung adenocarcinoma treatment market highlights
- The global metastatic lung adenocarcinoma treatment market generated a revenue of USD 4,896.4 million in 2024 and is expected to reach USD 9,288.1 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 11.3% by 2030.
- In terms of segment, chemotherapy accounted for a revenue of USD 1,913.8 million in 2024.
- Immunotherapy is the most lucrative treatment segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 4,896.4 million |
| Market revenue in 2030 | USD 9,288.1 million |
| Growth rate | 11.3% (CAGR from 2025 to 2030) |
| Largest segment | Chemotherapy |
| Fastest growing segment | Immunotherapy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Other |
Other key industry trends
- In terms of revenue, the North America accounted for 39.5% of the global metastatic lung adenocarcinoma treatment market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 104.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metastatic Lung adenocarcinoma Treatment Market Scope
Metastatic lung adenocarcinoma treatment market segmentation & scope
Metastatic Lung adenocarcinoma Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global metastatic lung adenocarcinoma treatment market size, by regions, 2018-2030 (US$M)
Top 10 countries: Metastatic lung adenocarcinoma treatment market size, 2024 (US$M)
Global metastatic lung adenocarcinoma treatment market share, by treatment, 2024 & 2030 (%, US$M)
Metastatic lung adenocarcinoma treatment market: Opportunity assessment by country
Global metastatic lung adenocarcinoma treatment market, by region, 2024 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
